Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Photo of Frank Moss
Individual Investor

Frank Moss

Overview

Edit Overview Section
Number of Portfolio Companies 1
Number of Exits 
Unlock for free
  • Investor Type 
    obfuscation
  • Investor Stage 
    obfuscation
  • Number of Exits 
    obfuscation
Frank Moss is the Member Board of Trustees of Jackson Laboratory.

Personal Investments

Edit Personal Investments Section
Number of Investments 1
Frank Moss invested in Infinity Pharmaceuticals on
obfuscation
. This investment - Series B - Infinity Pharmaceuticals - was valued at
obfuscation
.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Infinity Pharmaceuticals Logo
Infinity Pharmaceuticals
—
Series B - Infinity Pharmaceuticals Logo
Series B - Infinity Pharmaceuticals
obfuscation

Exits

Edit Exits Section
Number of Exits 
Unlock for free
Frank Moss has
obfuscation
exit - Infinity Pharmaceuticals. Frank Moss has
obfuscation
exits. Their most notable exits are Infinity Pharmaceuticals.
  • Infinity Pharmaceuticals Logo
    Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

Jobs

Edit Jobs Section
Number of Current Jobs 1
Number of Past Jobs 16
Frank Moss is the Member Board Of Trustees at The Jackson Laboratory. Additionally, Frank Moss has had 16 past jobs including Co-Founder, Chairman at Twine Health.
Organization Name  
Title At Company  
Start Date  
End Date  
Twine Health Logo
Twine Health
Co-Founder, ChairmanDec 2012Feb 2018
Matter.io Logo
Matter.io
Co-founder and ChairmanFeb 2013Feb 2017
Bluefin Labs Logo
Bluefin Labs
Co-founder and director20092013
Infinity Pharmaceuticals Logo
Infinity Pharmaceuticals
Co-Founder20012011
MIT Media Lab Logo
MIT Media Lab
Director20062011
Massachusetts Institute of Technology Logo
Massachusetts Institute of Technology
Director, Media LabFeb 1, 20062011
MIT Media Lab Logo
MIT Media Lab
Director, Wiesner Professor of Media Arts and Sciences20062011
Bowstreet Logo
Bowstreet
Co-Founder19982001
Bowstreet Logo
Bowstreet
Chairman and co-founder19982001
Tivoli Systems Logo
Tivoli Systems
CEO and president19911998

Board and Advisor Roles

Edit Board and Advisor Roles Section
Number of Current Board & Advisor Roles 5
Frank Moss holds 5 board and advisor roles including Member Board Of Trustees at The Jackson Laboratory, Chief Strategy Office at WEVO, and Member Board of Directors at ArtLifting.

Related Hubs

Edit Related Hubs Section
Hub Name  
CB Rank (Hub)  
Biopharma Companies With More Than 50 Employees Logo
Biopharma Companies With More Than 50 Employees
14,468
New England Companies With More Than 1000 Employees Logo
New England Companies With More Than 1000 Employees
10,856
New England Biotechnology Companies Logo
New England Biotechnology Companies
21,059
Product Research Companies With More Than 50 Employees Logo
Product Research Companies With More Than 50 Employees
21,790
Product Research Companies With Less Than $50M in Revenue Logo
Product Research Companies With Less Than $50M in Revenue
19,186
Product Research Companies With More Than 10 Employees Logo
Product Research Companies With More Than 10 Employees
15,255
Genetics Companies Logo
Genetics Companies
11,357
Michael J. Fox Foundation Portfolio Companies Logo
Michael J. Fox Foundation Portfolio Companies
70,838
Product Research Companies Logo
Product Research Companies
12,432
Maine Technology Institute Portfolio Companies Logo
Maine Technology Institute Portfolio Companies
85,995

Education

Edit Education Section
Frank Moss studied at Princeton University and  Massachusetts Institute of Technology.

Recent News and Activity

Edit Recent News and Activity Section
Number of News Articles 61
News•Sep 8, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 10, 2017
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 8, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 13, 2016
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 8, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 8, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 7, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 29, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 15, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 12, 2015
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
View All
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53d292a 1)
|